IL140716A0 - Use of inhibitors of protein kinase c epsilon to treat pain - Google Patents

Use of inhibitors of protein kinase c epsilon to treat pain

Info

Publication number
IL140716A0
IL140716A0 IL14071699A IL14071699A IL140716A0 IL 140716 A0 IL140716 A0 IL 140716A0 IL 14071699 A IL14071699 A IL 14071699A IL 14071699 A IL14071699 A IL 14071699A IL 140716 A0 IL140716 A0 IL 140716A0
Authority
IL
Israel
Prior art keywords
epsilon
inhibitors
pain
protein kinase
pkc epsilon
Prior art date
Application number
IL14071699A
Other languages
English (en)
Inventor
Robert O Messing
Jon D Levine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of IL140716A0 publication Critical patent/IL140716A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
IL14071699A 1998-07-06 1999-07-06 Use of inhibitors of protein kinase c epsilon to treat pain IL140716A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9175598P 1998-07-06 1998-07-06
US10376398P 1998-10-09 1998-10-09
PCT/US1999/015265 WO2000001415A2 (en) 1998-07-06 1999-07-06 Use of inhibitors of protein kinase c epsilon to treat pain

Publications (1)

Publication Number Publication Date
IL140716A0 true IL140716A0 (en) 2002-02-10

Family

ID=26784298

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14071699A IL140716A0 (en) 1998-07-06 1999-07-06 Use of inhibitors of protein kinase c epsilon to treat pain

Country Status (10)

Country Link
EP (1) EP1093379B1 (de)
JP (1) JP2002519391A (de)
AT (1) ATE350032T1 (de)
AU (1) AU764760B2 (de)
CA (1) CA2336709A1 (de)
DE (1) DE69934689T2 (de)
ES (1) ES2283120T3 (de)
IL (1) IL140716A0 (de)
NZ (1) NZ508767A (de)
WO (1) WO2000001415A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790192B2 (en) 1998-08-14 2010-09-07 Accessclosure, Inc. Apparatus and methods for sealing a vascular puncture
US7393835B2 (en) 2002-04-22 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Peptide inhibitors of protein kinase C
US6933275B2 (en) 2002-05-01 2005-08-23 The Board Of Trustees Of The Leland Stanford Junior University Protein kinase C peptides for use in withdrawal
WO2004084889A1 (en) * 2003-03-28 2004-10-07 Pfizer Inc. Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons
AU2003241559A1 (en) * 2003-05-16 2004-12-13 The Board Of Trustees Of The Leland Stanford Junior University Protein kinase c peptides for use in withdrawal
EP2228069A1 (de) 2003-09-16 2010-09-15 Garvan Institute Of Medical Research Antagonisten der Protein Kinase C-Epsilon (pkcepsilon) und deren Anwendungen für die Behandlung von damit im Zusammenhang stehenden aberranten Glukosestoffwechsel
WO2006095086A2 (fr) * 2005-03-07 2006-09-14 Laurence Faure Traçabilite des anomalies du cycle cellulaire ciblant l'oncologie et la neurodegenerescence.
US8221992B2 (en) * 2005-04-02 2012-07-17 Opsona Therapeutics Limited Assays for determining compounds which modulate TRAM phosphorylation
AU2006263332B2 (en) 2005-06-29 2012-02-23 Hadasit Medical Research Services & Development Ltd. Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
EP2177510A1 (de) 2008-10-17 2010-04-21 Universität des Saarlandes Allosterische Proteinkinasemodulatoren
JP2010090176A (ja) * 2010-01-26 2010-04-22 Board Of Trustees Of The Leland Stanford Junior Univ 離脱症状における使用のためのプロテインキナーゼcペプチド
US8785648B1 (en) 2010-08-10 2014-07-22 The Regents Of The University Of California PKC-epsilon inhibitors
JP6243850B2 (ja) * 2012-11-26 2017-12-06 学校法人近畿大学 抗がん剤による末梢神経障害の予防、治療、または軽減剤
EP3180003B1 (de) 2014-07-01 2022-01-12 The Regents of the University of California Pkc-epsilon-inhibitoren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141957A (en) * 1990-11-02 1992-08-25 Sphinx Pharmaceuticals Corporation 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
US5783405A (en) * 1994-02-01 1998-07-21 Terrapin Technologies, Inc. Rapid screening method for effectors of signal transduction
WO1997015575A1 (en) * 1995-10-27 1997-05-01 Procyon Pharmaceuticals, Inc. Protein kinase c modulators. y.

Also Published As

Publication number Publication date
NZ508767A (en) 2003-12-19
ES2283120T3 (es) 2007-10-16
WO2000001415A3 (en) 2000-04-13
JP2002519391A (ja) 2002-07-02
DE69934689T2 (de) 2007-10-25
ATE350032T1 (de) 2007-01-15
WO2000001415A2 (en) 2000-01-13
EP1093379A2 (de) 2001-04-25
AU764760B2 (en) 2003-08-28
CA2336709A1 (en) 2000-01-13
EP1093379B1 (de) 2007-01-03
DE69934689D1 (de) 2007-02-15
AU4863199A (en) 2000-01-24

Similar Documents

Publication Publication Date Title
AU3984597A (en) Formulation of 5-ht agonists
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
GEP20063885B (en) Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
NO980700D0 (no) Perifert aktive anti-hyperalgesi opiater
GEP20043363B (en) Indazole Compounds, Pharmaceutical Compositions, and Methods for Inhibiting Cell Proliferation
AU6257798A (en) Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
MX9803563A (es) Preparacion terapeutica para la administracion transdermica de principios activos.
WO2000001415A3 (en) Use of inhibitors of protein kinase c epsilon to treat pain
AU685075B2 (en) Pharmaceutical composition for treating nicotine dependence
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
AU4923093A (en) Inhibitors of metazoan parasite proteases
AU9551201A (en) Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic diseasestates
IL137489A0 (en) Pharmaceutical compositions containing inhibitors of the lymphotoxin pathway
WO2001030331A3 (en) Therapeutic compositions including protein kinase c inhibitors
MXPA03010672A (es) Composicion para el tratamiento regenerativo de enfermedades del cartilago.
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
AU3885799A (en) Antidepressant therapy
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
AU3600199A (en) A pharmaceutical composition containing ezrin mutated on tyrosine 353
AU5434899A (en) Cancer treatment
IL126158A0 (en) Method for treating substance abuse
WO2001045740A3 (en) Compositions and methods for treatment of breast cancer
AU8900498A (en) Compounds and pharmaceutical compositions thereof for eliciting analgesic effects
MY136408A (en) Active substance combinations and therapies for treating abuse of alcohol
AU2001262378A1 (en) Method for treating cryptorchidism